Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

International Journal of Clinical Oncology

Issue 2/2026

Content (16 Articles)

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; encorafenib for colorectal cancer, daratumumab for multiple myeloma, repotrectinib for NTRK-fusion positive solid tumors, and venetoclax for leukemia

Noriomi Matsumura, Masaki Mandai

Is neoadjuvant therapy necessary for resectable pancreatic cancer? A review of randomized controlled trials to date: a narrative review

Hidetoshi Eguchi

Cancer epidemiology in rare and hereditary colorectal diseases 2) anal canal cancer (cancer statistics)

Kazutaka Yamada, Yasumitsu Saiki, Shota Takano, Masafumi Tanaka, Mitsuko Fukunaga, Yasushi Nakamura, Keisuke Yonemura, Kosuke Sugimoto, Yuki Iwasaki, Yoriyuki Tsuji, Masahiro Takano

Microflora: a promising potential in the diagnosis and treatment of non-small cell lung cancer

Longfei Wang, Yange Chi, Min Zhang, Jiajun Jiang, Zihui Meng, Zhe Wang

Advances in endometrial cancer screening: a comprehensive review of current methods and emerging technologies

Mahsa Fatahichegeni, Zahra Haji Ghasem Sharbatdar, Mohammad Amin Ansarian

Prognostic and clinicopathological implications of mismatch-repair deficiency and MLH1 promoter methylation status in endometrial carcinoma

Mayuko Goda, Gou Yamamoto, Katsuya Iuchi, Koji Horie, Kiwamu Akagi

Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer

  • Open Access
  • Ascites
  • Original Article

Hsiu-Tzu Wang, Yung-Luen Yu, Wen-Jyi Lo, Mei-Chen Lin, Chien-Lun Chu, Chia-Yu Chen, Sing-Ting Wang, Chang-Fang Chiu, En-Jia Bai, Li-Yuan Bai

Clinical profiles and predictors of symptomatic skeletal events in patients with metastatic castration-resistant prostate cancer receiving denosumab

Mana Nakata, Fumihiko Urabe, Yu Imai, Kosuke Iwatani, Yuzo Inaba, Juria Nakano, Kensuke Fujiwara, Masaki Hashimoto, Yuhei Koike, Yuya Iwamoto, Shuhei Hara, Keiichiro Miyajima, Wataru Fukuokaya, Mahito Atsuta, Kagenori Ito, Keiichiro Mori, Takafumi Yanagisawa, Masaya Murakami, Kojiro Tashiro, Shunsuke Tsuzuki, Masato Yamaguchi, Tatsuya Shimomura, Jun Miki, Takahiro Kimura

Sustained antiemetic efficacy of fosnetupitant versus aprepitant in carboplatin-based chemotherapy: a retrospective observational study

Hiroshi Inano, Yoshihito Morimoto, Atsushi Kawamura, Taichi Ikegami, Tomoki Niizuma, Kanata Kitagawa, Rie Usami, Kozue Nakagomi, Yuri Anzo, Misaki Uchikawa, Haruki Yamamoto, Aiko Shono, Kazuhiro Watanabe, Katsuya Otori

Long-term progression-free survivors (“super responders”) to olaparib maintenance in recurrent ovarian cancer: a multicenter real-world study (KCOG-G2101s)

Naho Fukuda, Tsuyoshi Takashima, Hidekatsu Nakai, Emi Yoshioka, Kimihiko Ito, Roze Taniguchi, Hiroshi Tsubamoto, Takashi Motohashi, Satoe Fujiwara, Takahiro Katsuda, Shin Nishio, Hiroaki Nagano, Ryutaro Nishikawa, Kentaro Kai, Atsushi Arakawa, Kazuko Sakai, Eiichi Morii, Kazuto Nishio, Noriomi Matsumura

Real-world experience of circulating tumor DNA testing in resectable colorectal cancer: a Japanese single-institution observational study

Yuko Fukumoto, Kozo Kataoka, Yoshiko Muroi, Mizuki Koba, Kazuma Ito, Rao Zhenxin, Ayako Imada, Song Jihyung, Yuki Horio, Ryuichi Kuwahara, Motoi Uchino, Kei Kimura, Eiji Oki, Masataka Ikeda

Radiotherapy with or without chemotherapy for T2N0 hypopharyngeal cancer: an analysis of the head and neck cancer registry of Japan

Ari Nishimura, Naoki Fukuda, Daisuke Kawakita, Megumi Kitayama, Ken-ichi Nibu, Seiichi Yoshimoto, Hirokazu Uemura, Tadashi Kitahara

Impact of baseline regular magnesium oxide administration on chemotherapy-induced constipation during cisplatin-containing treatment

Yoshitaka Saito, Yoh Takekuma, Jun Sakakibara-Konishi, Yasushi Shimizu, Ichiro Kinoshita, Mitsuru Sugawara

The impact of neutropenia severity in the setting of recent chemotherapy on mortality in sepsis

Shreyas Shirodkar, Saad Javaid, Jennifer Collins, Khawaja Omar, Amir Kamran

Longitudinal assessment of health-related quality of life, sleep quality, and gustation in patients with advanced urothelial carcinoma receiving late-line enfortumab vedotin monotherapy

Makito Miyake, Nobutaka Nishimura, Yuki Oda, Takuto Shimizu, Takuya Owari, Kota Iida, Yasushi Nakai, Nobumichi Tanaka, Kiyohide Fujimoto

Sequential changes in conditional survival of patients following surgical resection of colorectal cancer and indicators for follow-up beyond 5 years

Ryotaro Goto, Hideo Miyake, Hidemasa Nagai, Yuichiro Yoshioka, Junichi Takamizawa, Norihiro Yuasa

Jan 26
Issue: 1/2026
Mar 26
Issue: 3/2026

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Case simulations: Biomarker-driven management of NSCLC (Link opens in a new window)

Do you want to assess your biomarker testing skills and management decisions? Use these simulation-based case studies based on realistic NSCLC scenarios to do so in a practical and secure environment.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
COMMISSIONED

How-to guide for healthcare professionals: understanding genomic reports

This educational activity was initiated, funded and co-developed by Boehringer Ingelheim and is intended for healthcare professionals in the UK and Ireland only. 

Genomic testing helps inform cancer diagnosis, prognosis, and treatment. A genomic report is generated by the laboratory carrying out next-generation sequencing to analyze biopsy samples. Access this educational microsite to learn more about typical genomic report content and how to interpret test results for patients with cancer.

NP-GB-106631 | Jan 2026

Commissioned by:
  • Boehringer Ingelheim
Learn more
Image Credits
Biomarker-driven management of NSCLC logo/© Springer Health+ IME, DNA double helix structure on a purple background/© 2025 Adobe